Welcome to the AkPharma.com website

 

Clinical and Laboratory Studies / Articles

 utilizing Calcium Glycerophosphate

 in Respiratory, Dermatological and Urological Applications


 

 

 

# = Studies generated or underwritten by AkPharma Inc.
Note: Links connect with publication sites. Published abstracts accessible free in some cases; charge applies to others if not journal subscriber. All AkPharma-generated material (marked by #) is accessible via direct link on this site from article or study location.

 

RESPIRATORY

 

# Calcium Glycerophosphate Nasal Spray Reduces Rhinitis Symptoms; Schulman E, Hendry M, Sherman M, Weis M; Drexel Univ Col of Med; Am Acad Allergy, Asthma & Immun pres; Nov 2015 (Poster)


DREXEL-SCHULMAN RESPIRATORY STUDY – SAN ANTONIO POSTER PRESENTATION


DREXEL-SCHULMAN RESPIRATORY STUDY FINAL WRITEUP


DREXEL-SCHULMAN RESPIRATORY STUDY IN CLINICAL TRIALS.GOV.PDF


Report.pdf


# Effects of AkPharma’s Calcium Glycerophosphate Nasal Spray Wash (AkP010112A) on Patient-Perceived Breathing Comfort; Lovelace Scientific Resources, Inc., Albuquerque, NM; Nov 2014 (Unpublished)


LOVELACE STUDY – CORRECTION TO TABLE.PDF


# Acoustic Rhinometry and Pathologic Analysis on Ovalbumin-Sensitized Guinea Pigs Treated with Calcium Glycerophosphate; Brackee G & Weis M, Texas Tech Univ. Lab. Animal Res Ctr, Lubbock Campus, TX; Dec 5, 2011 (Unpublished)


# Effects of Inhaled Calcium Glycerophosphate on Rhinitis Responses in Ragweed Sensitized Dogs – FY09-133; Lovelace Respiratory Research Institute, Albuquerque, NM, March 2010 (Unpublished)

 


DERMATOLOGY/WOUND CARE/SOFT TISSUE/INTESTINAL CELL


Boston poster 2015


Weis – TTU – alpha vs. beta GP in tight junctional integrity report – 06-10-06


Caco-2 cells – 2nd Exp. by Weis & Datta – Writeup – June 2015


Caco-2 Study Report – 10-01-14
 


JWC_20_12_592_598_Weis_Print


# An RCT on the Effects of Topical CGP on Surgical Wound Appearance and Residual Scarring in Bilateral Total-Knee Arthroplasty Patients; Ong A, Orozco F, Sheikh ES, Anmuth C, Alfaro A, Kathrins R, Grove GL, Zerweck C, Madden AM, Raspa R, Weis MT; J. Wound Care, 20:12, 592-598, Dec 2011


ATTOEAC3.PDF
 


# A set of sequential photographic observations on a pair of facial (nasal) excision scars on a 70-year old female, one scar treated with AkPharma’s CGP-content aqueous lotion vs. one scar untreated – 2005    
s-s observ 1 page


# A set of sequential photographic observations on a middle-aged male with hot iron pipe burn trauma on arm, one half the burn treated with AkPharma’s CGP-content aqueous lotion vs. one half untreated – 2005
 


# 2003-2009 – Sequence of AkPharma-Sponsored Skin Effects Studies using Calcium Glycerophosphate (CGP)

(all unpublished)


(1) Dansyl Chloride Cell Renewal Study to Evaluate the Ability of a Topically Applied Test Formulation to Enhance Epidermal Cell Renewal; KGL #5305A, Skin Study Center – Ivy Laboratories, KGL Inc, Broomall, PA, 20 Jan 2004


(2) Leg Regression Study to Evaluate the Efficacy of a Test Product Formulation Containing Calcium Glycerophosphate as a Dermal Treatment; KGL #5305B, Skin Study Center – Ivy Laboratories, KGL Inc, Broomall, PA, 20 Jan 2004


(3) Dansyl Chloride Cell Renewal Study to Evaluate the Ability of Two Topically Applied Test Formulations to Enhance Epidermal Cell RenewalKGL #5698, Skin Study Center – Ivy Laboratories, KGL Inc, Broomall, PA, 20 Jan 2005


(4) A Single-Blind, Randomized, Controlled Pilot Study with Topical Calcium Glycerophosphate in Patients with Tape-Strip Damaged Skin# TOPCGP-2005, CyberDERM Clinical Studies, Broomall, PA, 17 Feb 2006


(5) A Randomized, Controlled Pilot Study Assessing Topical Calcium Glycerophosphate as a Potential Agent for Minimizing Damage due to Adhesive Dressings; Research Report SO6-15, CyberDERM Clinical Studies, Broomall, PA, 24 March 2006


(6) A Randomized, Controlled 5 Day Pilot Study Assessing Topical Calcium Glycerophosphate as a Potential Agent for Minimizing Skin Damage due to Adhesive Dressings; Research Report SO6-19, CyberDERM Clinical Studies, Broomall, PA, 19 June 2006


(7) A Randomized, Controlled Pilot Study Comparing Potential Agents for Minimizing Damage due to Adhesive Dressings; Research Report SO6-92, CyberDERM Clinical Studies, Broomall, PA, 16 Nov 2006


(8) A Single Blind,Randomized, Controlled Long Term Leg Regression Study with TFA SO6-87 in Patients with Moderate to Severe Dry Skin; Research Report SO6-87, CyberDERM Clinical Studies, Broomall, PA, 22 Dec 2006


(9) 5 Day Anti-Inflammatory Test Using Skin Trauma After Razor Shaving Bioassay; Research Report SO7-54, CyberDERM Clinical Studies, Broomall, PA, 14 Sep 2007


(10) 4-Day Hand Study Pilot to Determine the Potential Benefits of Topical CGP Formulations on Chapped Hands; Research Report SO9-18, CyberDERM Clinical Studies, Broomall, PA, 2 Apr 2009


 (11) 24 Hour Modified Soap Chamber Study to Assess Calcium Glycerophosphate as a Potential Agent for Reducing Skin Irritation from Dishwashing Liquids; Research Report SO9-27, CyberDERM Clinical Studies, Broomall, PA, 7 July 2009

 


UROLOGY/INTERSTITIAL CYSTITIS – utilizing/citing Calcium Glycerophosphate


The Effectiveness of Calcium Glycerophosphate (Prelief®) in Decreasing Symptoms of Interstitial Cystitis and Improving Quality of Life of Patients with Food-related Exacerbations; Bologna, RA, et al;, Phila, PA, and #Use of Prelief With Foods and Subjective Responses, Whitmore et al, Graduate Hosp, Phila, PA, 1998– Slides


The Effects of Use of Calcium Glycerophosphate in Patients’ Perception of Pain From Interstitial Cystitis Using NMP as a Marker – Poster and Slides – DiTrolio et al – AUA NYC Session Meeting Display 2005


DiTrolio et al – CGP Effects on Bladder per NMP – c.2005.pdf
Interstitial Cystitis, Painful Bladder Syndrome, Bladder Pain Syndrome, Hypersensitive Bladder Syndrome, Chronic Pelvic Pain, Diagnosis & Treatment – An Overview; Meijlink JM; Intl Painful Bladder Found, IPBF Publication No. 1, Aug 2011

 

NON-CLICKABLE FURTHER REFERENCES..


Dietary Consumption Triggers in Interstitial Cystitis/Bladder Pain Syndrome Patients; Bassaly R, et al; Female Pelvic Med Reconstructive Surgery, 17.1: 36-39, 2011


Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome – AUA Guideline; Hanno P, et al, p 17 col 1, Sep 2014


Interstitial Cystitis Patients’ Use and Rating of Complementary and Alternative Medicine Therapies; Hoffmann A, et al; Intl Continence Soc (ICS) Ann Mtg,Toronto (Poster), Aug 23-27, 2010


Minimally Invasive Therapies for Chronic Pelvic Pain Syndrome; Wehbe SA, et al; Current Urology Reports, 11.4: 276-285, 2010


Urologic Chronic Pelvic Pain Syndrome; Martinez-Bianchi V, et al; Prim Care Clinic Office Practice, 37.3: 527-546, 2010


Differences in Food Sensitivities Between Female Interstitial Cystitis/Painful Bladder Syndrome (IC/ PBS) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) Patients; Herati AS, et al; American Urological Association Annual Meeting (Study Presentation), Chicago, IL (Poster) Apr 25-30, 2009


Interstitial Cystitis; Myers DL; Medicine & Health/Rhode Island, 92.1: 22-26, 2009


Patient Perceived Outcomes of Treatments Used for Interstitial Cystitis; Hill, JR, et al; Urology, 71.1:62-66, 2008

# Complementary and Alternative Therapies as Treatment Approaches for Interstitial Cystitis; Whitmore KE; Reviews in Urology; 4 (Supplement 1): S28–S35, 2002


The Painful and Overactive Bladder Syndromes: Interstitial Cystitis: a Pathophysiology and Treatment Update; Moldwin RM & Sant GR; Clinical Obstetrics & Gynecology: Vol. 45, Issue 1, 259-272; March 2002


# The Efficacy of Calcium Glycerophosphate in the Prevention of Food-Related Flares in Interstitial Cystitis; Bologna RA, et al; Urology Supplement (Vol. 57-6A, 119-120), June 2001


Solving the Interstitial Cystitis Mystery; Willis A; Los Angeles: Holistic Life Enterprises, pp. 17-18, 2001


Drug Update: Interstitial Cystitis; Zoler ML, et al; OB/GYN News, Dec 1, 2001


The Therapeutic Effect of Calcium Glycerophosphate (Prelief®) in Interstitial Cystitis; Jones, P; Interstitial Cystitis Support Group (ICSG), United Kingdom; 2000 [Not a clinical study; survey by support association]


# Survey of the Effect of Prelief on Food-Related Exacerbation of Interstitial Cystitis Symptoms (statistical analysis and summary); Visintainer PF; New York Medical College, Valhalla, NY, 1999


Interstitial Cystitis: Update on Etiologies and Therapeutic Options; Erickson, DR; J Woman's Health Gender Based Med, Vol. 8,

No. 6. (1999), pp. 745-758
 


 

Contact: AkPharma Inc., PO Box  111, Pleasantville, NJ 08232 – Phone  609/645-5100 – Fax 609/645-0767
 Or use the form below to contact
Alan E. Kligerman, CEO or Kathy Jamison, Manager, Contracts and Purchasing.